Moeve Joins Global Impact Coalition
The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.
News
MSD Licenses Cardiovascular Drug from Hengrui Pharma
MSD (Merck & Co.) and Hengrui Pharma recently announced that they have entered into an exclusive license agreement for HRS-5346, an investigational oral small molecule Lipoprotein(a) inhibitor.
CEFIC President Calls for EU Action on Chemicals Rescue Plan
Europe's chemical industry is in crisis, warns the European Chemical Industry Council (CEFIC) President Ilham Kadri, urging EU leaders to act on a 10-point rescue plan to prevent further shutdowns and loss of investments.
Carbon Recycling Collaboration at Mizushima Complex
JFE Steel, Mitsubishi Gas Chemical, and Mitsubishi Chemical collaborate to develop a carbon recycling supply chain at Mizushima Complex.
OMV Opens Plant for Plastic Recycling
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
Coco Custo – Clean Clothes, Cleaner Ingredients, Clean Sea
The Indian, woman-led startup Coco Custo is pioneering more sustainable cleaning solutions with its biodegradable laundry detergent and other eco-friendly cleaning powders. Formulated primarily from plant-based ingredients and minerals, including organic oils and coconut, Coco Custo’s products are non-toxic, hypoallergenic, and free from harmful chemicals.
AstraZeneca to Establish Global Drug Research Center in Beijing
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
What’s Next for Pharma Supply Chains?
Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.
Arkema Launches Acrylic Acid Purification Project
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
DE&I Cuts: What’s at Stake for the Chemical Industry?
Diversity, equity, and inclusion (DE&I) initiatives have become increasingly important for attracting diverse perspectives, improving problem solving and advancing innovation in companies.
Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Sustainable Paper Additives
Paper is a sustainable material by nature. However, many paper products need to be treated with additives such as wet strength agents or sizing agents to improve their properties for certain applications.
Data-Driven Enzyme Immobilization
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
High-Performance Adsorbents: The Future of Clean Industry
Porelio's FOMS adsorbents target PFAS, metals, and genotoxins, outperforming commercial solutions with unmatched selectivity, innovation, and sustainability.
Increasing Complexity of Pharma Logistics
The pharmaceutical industry requires reliable and innovative partners who can flexibly adapt to its changing demands.
New Deal to Boost Competitiveness
The EU Green Deal has hurt Europe's industry. The Clean Industrial Deal aims to improve this, but a change of mindset at the Commission is needed.
PMMA as an Ideal Material for the Circular Economy
The versatile material polymethyl methacrylate (PMMA) is particularly impressive due to its durability and outstanding recyclability.
Roche and Zealand Pharma Collaborate on Weight Management Drug
Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.
BASF Signs Offtake Agreement with Braven for Recycled Feedstock
BASF and Braven Environmental, a market leader in advanced recycling, have signed a supply agreement for Braven PyChem. This recycled feedstock, derived from mixed plastic waste, will partially replace fossil resources at the BASF TotalEnergies Petrochemical (BTP) facility in Port Arthur, Texas, US, the companies said. Under the agreement, Braven will supply BASF from a multi-unit facility that it plans to build in Texarkana, Texas.
Sun Pharma to Acquire Checkpoint Therapeutics
Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.
Syngene Acquires its First US Manufacturing Facility
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
Axplora Expands Capabilities at Le Mans Site
Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).
Adragos Pharma Commissions New Liquid Filling Line at German Site
German contract development and manufacturing organization (CDMO) Adragos Pharma has completed a €4 million project to install and commission a new, cGMP-compliant liquid drug filling line and associated cartoning machine at its plant in Leipzig, Germany.
Rio Tinto Completes Acquisition of Arcadium Lithium
Rio Tinto has completed the $6.7 billion acquisition of Arcadium Lithium and is now the parent company of Arcadium Lithium, which will be renamed Rio Tinto Lithium and will also include the Rincon Lithium Project.
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million
Ireland’s Jazz Pharmaceuticals signed an agreement to acquire its compatriot Chimerix for approximately $935 million. The transaction is expected to close in the second quarter of 2025.
CordenPharma Expands Peptide Manufacturing Platform in Switzerland
Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.
ADNOC and OMV to Create Global Polyolefins Group
OMV and ADNOC agreed to combine their Borealis and Borouge shareholdings into Borouge Group International. ADNOC has also signed a share purchase agreement with Nova Chemicals, an indirect wholly owned subsidiary of Mubadala Investment Company, to acquire 100% of Nova Chemicals for an enterprise value of $13.4 billion. In addition, ADNOC and OMV have agreed for Borouge Group International to take over Nova Chemicals after closing.
WE Soda Buys Soda Ash Producer Genesis Alkali
WE Soda has acquired Genesis Alkali (Alkali), the largest US-based producer of natural soda ash, from Genesis Energy in an all-cash transaction for $1.425 billion.
AbbVie Teams up with Gubra to Develop Obesity Treatment
The US pharmaceutical giant AbbVie and Danish biotechnology company Gubra, specializing in preclinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, signed a license agreement to develop GUB014295, a potential best-in-class, long-acting amylin analog for the treatment of obesity.
Toray Opens R&D Center in Taiwan for Semiconductors
Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.
Mavisol – Innovative AI and Machine Vision Solutions for rPET Industry
Dutch start-up Mavisol has developed an innovative machine vision and AI solution designed specifically for plastic converters, with the aim of promoting environmental sustainability and improving material reuse efficiency.
Anchoring Plastics as the Foundation of Industry in the EU Clean Industrial Deal
Plastics Europe strongly supports the European Commission's competitiveness and decarbonization agenda and welcomes the Clean Industrial Deal.
Lilly to Expand US Drug Manufacturing with $27 Billion Investment
Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.
Arkema to Increase its PVDF Capacity in North America
The 15% capacity expansion of Arkema’s PVDF production site in Calvert City, Kentucky, represents an investment of approximately $20 million (€19 million).
European Chemical Industry Becoming Extinct
Ahead of the unveiling of the EU’s Clean Industrial Deal, Ineos Chairman and CEO, Sir Jim Ratcliffe, authored an open letter to emphasize the importance of supportive political decisions and measures for the European industry. Releasing the open letter, Ineos stated: “A year on from the signing of ‘The Antwerp Declaration for a European Industrial Deal’ we have not seen the action necessary to stem the decline of European industry. Ineos has continued to invest in Europe; however, it is now an exception in a landscape of deindustrialization and closures.” Please read the complete open letter below:
